Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Rheumatology
•
Inflammatory Bowel Disease
•
General Rheumatology
•
Infectious Disease
•
Tuberculosis
•
Gastroenterology
Would you hold all immunosuppressive medications for the first month of LTBI treatment, or just biologics?
Answer from: at Community Practice
This video might answer your question: QD Clinic - Lessons from the clinic - Dx and Treating LTBI with a TNFI inhibitor features Dr. Jack Cush
Sign in or Register to read more
8802
Related Questions
How do you approach ongoing screening for TB in patients with a history of treated latent TB, but who have ongoing use of DMARDs and/or biologics given Quantiferon testing and PPD can remain positive?
Should patients starting cyclophosphamide be screened routinely for latent tuberculosis (TB)?
Is there a risk of hepatitis C activation with rituximab in a patient who has a history of HCV treated with antivirals and who is in sustained viral response?
Does your institution have formal policies or work flows to reduce unnecessary IGRAs ordered for patients on biologics?
Is there a role for nitazoxanide for treatment of norovirus gastroenteritis in immunocompromised patients?
How do you counsel patients who experience diarrhea from mycophenolate mofetil (Cellcept)?
Are there any concerns with live vaccine innoculation and patients who are on denosumab?
What aspects of a patients clinical presentation would make you consider a diagnostic challenge of anakinra to assess for an underlying auto-inflammatory syndrome in hospitalized patient with fever of unknown origin?
How would you treat an asymptomatic patient with a positive Blastomyces antibody, evidence of prior granulomatous lung disease on imaging, and who may require immunosuppression in the future?
How would you manage a patient with highly active ankylosing spondylitis, iritis and Crohn’s, controlled with weekly adalimumab with co-morbid IgG4RD and intolerance of azathioprine due to elevated LFTs?